JP2021530237A5 - - Google Patents

Info

Publication number
JP2021530237A5
JP2021530237A5 JP2021503011A JP2021503011A JP2021530237A5 JP 2021530237 A5 JP2021530237 A5 JP 2021530237A5 JP 2021503011 A JP2021503011 A JP 2021503011A JP 2021503011 A JP2021503011 A JP 2021503011A JP 2021530237 A5 JP2021530237 A5 JP 2021530237A5
Authority
JP
Japan
Prior art keywords
antigen
antibody
binding fragment
item
campylobacter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2021503011A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021530237A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/042070 external-priority patent/WO2020018584A2/en
Publication of JP2021530237A publication Critical patent/JP2021530237A/ja
Publication of JP2021530237A5 publication Critical patent/JP2021530237A5/ja
Priority to JP2024092422A priority Critical patent/JP2024116266A/ja
Ceased legal-status Critical Current

Links

JP2021503011A 2018-07-17 2019-07-16 Campylobacterの種に対する抗体 Ceased JP2021530237A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024092422A JP2024116266A (ja) 2018-07-17 2024-06-06 Campylobacterの種に対する抗体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862699573P 2018-07-17 2018-07-17
US62/699,573 2018-07-17
PCT/US2019/042070 WO2020018584A2 (en) 2018-07-17 2019-07-16 Antibodies against campylobacter species

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024092422A Division JP2024116266A (ja) 2018-07-17 2024-06-06 Campylobacterの種に対する抗体

Publications (2)

Publication Number Publication Date
JP2021530237A JP2021530237A (ja) 2021-11-11
JP2021530237A5 true JP2021530237A5 (cg-RX-API-DMAC7.html) 2022-07-11

Family

ID=67480448

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021503011A Ceased JP2021530237A (ja) 2018-07-17 2019-07-16 Campylobacterの種に対する抗体
JP2024092422A Pending JP2024116266A (ja) 2018-07-17 2024-06-06 Campylobacterの種に対する抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024092422A Pending JP2024116266A (ja) 2018-07-17 2024-06-06 Campylobacterの種に対する抗体

Country Status (13)

Country Link
US (1) US12297258B2 (cg-RX-API-DMAC7.html)
EP (1) EP3823727A2 (cg-RX-API-DMAC7.html)
JP (2) JP2021530237A (cg-RX-API-DMAC7.html)
KR (1) KR20210041557A (cg-RX-API-DMAC7.html)
CN (1) CN112867541B (cg-RX-API-DMAC7.html)
AU (1) AU2019306543A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021000772A2 (cg-RX-API-DMAC7.html)
CA (1) CA3105222A1 (cg-RX-API-DMAC7.html)
EA (1) EA202190194A1 (cg-RX-API-DMAC7.html)
IL (1) IL280234A (cg-RX-API-DMAC7.html)
MX (1) MX2021000268A (cg-RX-API-DMAC7.html)
SG (1) SG11202013193XA (cg-RX-API-DMAC7.html)
WO (1) WO2020018584A2 (cg-RX-API-DMAC7.html)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5959177A (en) 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
US5283173A (en) 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5770429A (en) 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
EP0604580A1 (en) 1991-09-19 1994-07-06 Genentech, Inc. EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab') 2? ANTIBODIES
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6040498A (en) 1998-08-11 2000-03-21 North Caroline State University Genetically engineered duckweed
US6833268B1 (en) 1999-06-10 2004-12-21 Abgenix, Inc. Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
KR100797667B1 (ko) 1999-10-04 2008-01-23 메디카고 인코포레이티드 외래 유전자의 전사를 조절하는 방법
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
WO2004076677A2 (en) 2003-02-26 2004-09-10 Institute For Research In Biomedicine Monoclonal antibody production by ebv transformation of b cells
WO2005028515A1 (ja) 2003-09-24 2005-03-31 Kyowa Hakko Kogyo Co., Ltd. ヒトインスリン様成長因子に対する遺伝子組換え抗体
ES2358804T3 (es) * 2003-11-21 2011-05-13 Ace Biosciences A/S Polipéptidos de campylobacter jejuni ubicados en superficie.
GB0423681D0 (en) * 2004-10-26 2004-11-24 Sec Dep For Environment Food & Vaccine and nucleic acids
WO2008042814A2 (en) 2006-09-29 2008-04-10 California Institute Of Technology Mart-1 t cell receptors
MX2015005304A (es) 2012-10-24 2016-04-04 Nat Res Council Canada Anticuerpo contra campylobacter jejuni y usos para los mismos.
EP2995679A4 (en) 2013-03-11 2016-12-14 Kansai Bunri Sogo Gakuen PROCESS FOR PREPARING MONOCLONAL IGA ANTIBODIES

Similar Documents

Publication Publication Date Title
JP2021526022A5 (cg-RX-API-DMAC7.html)
CN111620945A (zh) 一种抗新型冠状病毒的单克隆抗体或其衍生体
AU2012269720B2 (en) Antibodies against G-CSFR and uses thereof
RU2019140602A (ru) АНТИ-GARP-TGF-β-АНТИТЕЛА
WO2017164678A2 (ko) 중증열성혈소판감소증후군 바이러스의 외막 당단백질에 결합하는 항체 및 이의 용도
EP4036113B1 (en) Humanized anti-il17a antibody and use thereof
JP2024105229A5 (cg-RX-API-DMAC7.html)
EP3656789A1 (en) Antibody targeting interleukin 17a and preparation method and application thereof
AU2023216791A1 (en) Antibodies with improved stability to intestinal digestion
WO2019061962A1 (zh) 一种抗白介素17a的抗体、其制备方法和应用
CA3166346A1 (en) Anti-angptl3 antibody and use thereof
CN114805570B (zh) 一种抗人ace2单克隆抗体及其应用
WO2018088850A2 (ko) Cd40에 특이적으로 결합하는 항체 및 그의 용도
EP2822966B1 (en) Treatment of mucositis with immunoglobulin a
CN115038497A (zh) TGF-β-RII结合蛋白质
JP2019518473A5 (cg-RX-API-DMAC7.html)
TW202309076A (zh) 用於治療α-突觸核蛋白病之抗體
IL277899B2 (en) Methods and preparations for treating yellow fever
WO2014061783A1 (ja) クロストリジウム・ディフィシルの毒素に特異的なヒト抗体もしくはその抗原結合性断片
CN119119253A (zh) 靶向结合腮腺炎病毒的抗体或其抗原结合片段
WO2014160098A2 (en) Bordetella specific human recombinant antibodies and uses thereof
WO2021258625A1 (zh) 抗sar-cov-2(covid-19)全人源单克隆抗体及其制法与应用
WO2021248276A1 (zh) 一种抗sar-cov-2抗体或其抗原结合片段及其应用
KR102087743B1 (ko) IL-1beta에 특이적으로 결합하는 항체 및 그의 용도
CN116023475B (zh) 抗sars-cov-2全人源单克隆抗体及其制法与应用